Back

The selective late sodium current inhibitor eleclazine reduces atrial fibrillation dominant frequency and facilitates the suppression of arrhythmia in HL-1 cells

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Basic Science Cardiac ePosters Arrhythmias ESC Premium Access ESC Congress 2020

About the speaker

Photo
Miss Irene Del Canto Serrano

University of Valencia, Valencia (Spain)

110 More presentations in this session

Presentation thumbnail
Elimination of senescent cells targeting Senescence associated glycoprotein (SAGP) improved the ageing-associated diseases and extended the lifespan
Doctor M. Suda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Single-cell RNA sequencing of human fetal epicardium reveals novel markers and regulators of EMT
Mr T. Streef (Leiden, NL)
Abstract Slides
Presentation thumbnail
Genome-wide association study identifies 18 new susceptibility variants loci associated with Brugada Syndrome
Associate Professor J. Barc (Nantes, FR)
Abstract Slides
Presentation thumbnail
Mutations in CHMP4C cause dilated cardiomyopathy via dysregulation of autophagy
Doctor N. Zhou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Disruption of the architecture of the junctional sarcoplasmic reticulum in recessive catecholaminergic polymorphic ventricular tachycardia is caused by the er-shaping proteins reep5 and climp63
Doctor R. Bongianino (Pavia, IT)
Abstract Slides

Access the full session

Session thumbnail
Basic Science Cardiac ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources